tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Nick Abbott, 8 are a HOLD (53.33%), 7 are a BUY (46.67%).
Analyst Nick Abbott, carries an average stock price target met ratio of 42.86% that have a potential upside of 25.39% achieved within 128 days.
Nick Abbott’s has documented 27 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on IOVA, Iovance Biotherapeutics at 01-Mar-2024.
Analyst best performing recommendations are on IOVA (IOVANCE BIOTHERAPEUTICS).
The best stock recommendation documented was for IOVA (IOVANCE BIOTHERAPEUTICS) at 2/26/2020. The price target of $38 was fulfilled within 9 days with a profit of $4.35 (12.93%) receiving and performance score of 14.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Oct-2021
$69
$19.44 (39.23%)
$63
1 months 8 days ago
(23-Feb-2026)
41/67 (61.19%)
$18.71 (37.20%)
81
7.26
Hold Since 05-Aug-2024
$30
$-19.56 (-39.47%)
$25
1 months 14 days ago
(17-Feb-2026)
10/18 (55.56%)
$-13.93 (-31.71%)
91
2.15
Hold Since 20-Jul-2020
$35
$-14.56 (-29.38%)
$32
1 months 14 days ago
(17-Feb-2026)
7/9 (77.78%)
$-8.93 (-20.33%)
79
3.3
Hold Since 29-Jan-2025
$41
$-8.56 (-17.27%)
$51
1 months 14 days ago
(17-Feb-2026)
14/26 (53.85%)
$-2.93 (-6.67%)
97
6.13
Hold Since 07-Jan-2026
$34
$-15.56 (-31.40%)
$40
2 months 24 days ago
(07-Jan-2026)
6/15 (40%)
$-1.89 (-5.27%)
71
5.98
What Year was the first public recommendation made by Nick Abbott?
